Product Code: MRFR/MED/0803-CR
Medical Robotics Market Research Report Forecast 2030
Market Overview
Medical Robotics Market is anticipated to register a largest CAGR of 15.69% during the review period.
Developing utilizations of medical robotics is one of the central point driving the development of the Medical Robotics Market. In like manner, mechanical headways and expanding key drives are further powering the development of the worldwide market during the audit time frame.
Surgical robotics has arisen as another development point and mechanical hatchery in present day medical procedure. Robot-helped medical procedures were created to expand the capacities of specialists while carrying out open procedures on a patient or to address the restrictions of existing insignificantly intrusive medical procedure innovations. Negligibly obtrusive medical procedure with surgical robotics supports diminishing recuperation time, speeding up mending, and in abstaining from scarring. The expanded requirement for negligibly obtrusive surgical therapies, as well as the utilization of medical robotics in aiding surgical strategies, have essentially worked on the viability of surgical activities. In this way, the previously mentioned factors are advancing market development.
Market Segmentation
The type-based segmentation of the medical robotics market covers consumables, services, and equipment.
Surgical robots, rehabilitation robots, noninvasive radiosurgery robots, hospital and pharmacy robots, emergency response robotic systems, logistics/handling robotic systems, and imaging robotic systems are all included in the product-based segmentation of the medical robotics market.
The global medical robots' market is divided into subsectors according to application, including neurology, orthopedics, cardiology, oncology, laparoscopy, aesthetic surgery, rehabilitation, and angiography.
The market is divided into three categories: homecare, in-patient, and out-patient. Hospitals & clinics, specialized centers, rehabilitation facilities, and other establishments are included in the end user segment.
Regional Insights
The North America medical robotics market addressed the greatest market share in 2022. Key factors credited to it are the rising capability of medical robots in performing endeavors that recall medical systems for the geriatric people and mounting cases of injury wounds are a part of the fundamental contemplations driving the improvement of the medical robotics market in the region.
Europe medical robotics market addressed the second-greatest market share due to growing geriatric people in the made countries and the globalization of medical administrations. In addition, the Germany medical robotics market attributed to hold the greatest market share, and the France medical robotics market is expanded be the speediest creating market in the Europe region.
The Asia-Pacific medical robotics market should be the fastest creating from 2023 to 2030 in view of the rising geriatric people and the climb in the interest for irrelevantly prominent and effortless surgical frameworks. rising geriatric people and the climb in the interest for unimportantly prominent and innocuous surgical methods. Moreover, China medical robotics market accounted to hold the greatest market share, and the India medical robotics market is projected to be the speediest creating market in the Asia-Pacific region.
Major Players
Key Companies in the medical robotics market are Auris Health Inc. (US), Medtronic (Ireland), Zimmer Biomet (US), Renishaw Plc. (UK), Health Robotics S.R.L (Europe), Stryker (US), Smith+Nephew (UK), Intuitive Surgical (US), KUKA AG (Germany), and CMR Surgical (UK).
TABLE OF CONTENTS
TABLE OF CONTENTS
1 EXECUTIVE SUMMARY
- 1.1 DEFINITION
- 1.2 SCOPE OF THE STUDY
- 1.3 RESEARCH OBJECTIVE
- 1.4 LIST OF ASSUMPTIONS
2 RESEARCH METHODOLOGY
- 2.1 OVERVIEW
- 2.2 DATA MINING
- 2.3 SECONDARY RESEARCH
- 2.4 PRIMARY RESEARCH
- 2.4.1 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS
- 2.4.2 BREAKDOWN OF PRIMARY RESPONDENTS
- 2.5 FORECASTING TECHNIQUES
- 2.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION
- 2.6.1 BOTTOM-UP APPROACH
- 2.6.2 TOP-DOWN APPROACH
- 2.7 DATA TRIANGULATION
- 2.8 VALIDATION
3 MARKET DYNAMICS
- 3.1 OVERVIEW
- 3.2 DRIVERS
- 3.2.1 GROWING APPLICATIONS OF ROBOTS IN HEALTHCARE
- 3.2.2 GROWING INITIATIVES AND DEVELOPMENT MOVEMENTS IN THE MARKET HELPS IN THE GROWTH
- 3.2.3 TECHNOLOGICAL ADVANCEMENTS IN MEDICAL ROBOTICS
- 3.3 RESTRAINTS
- 3.3.1 HIGH COST OF ROBOTS
- 3.4 OPPORTUNITIES
- 3.4.1 RISING DEMAND FOR AUTOMATION
4 MARKET FACTOR ANALYSIS
- 4.1 VALUE CHAIN ANALYSIS
- 4.1.1 R&D AND DESIGNING
- 4.1.2 MANUFACTURING
- 4.1.3 DISTRIBUTION & SALES
- 4.1.4 POST-SALES SERVICES AND REVIEW
- 4.2 PORTER'S FIVE FORCES MODEL
- 4.2.1 THREAT OF NEW ENTRANTS
- 4.2.2 BARGAINING POWER OF SUPPLIERS
- 4.2.3 THREAT OF SUBSTITUTES
- 4.2.4 BARGAINING POWER OF BUYERS
- 4.2.5 INTENSITY OF RIVALRY
- 4.3 IMPACT OF COVID-19
- 4.3.1 OVERVIEW
- 4.3.2 IMPACT ON DEMAND
- 4.3.3 IMPACT ON THE SUPPLY CHAIN
- 4.3.4 IMPACT ON KEY PLAYERS
- 4.4 MEDICAL ROBOTIC SYSTEMS INSTALLED BASE AND ASP
5 GLOBAL MEDICAL ROBOTICS MARKET, BY TYPE
- 5.1 OVERVIEW
- 5.2 EQUIPMENT
- 5.3 SERVICE
- 5.4 CONSUMABLES
6 GLOBAL MEDICAL ROBOTICS MARKET, BY PRODUCT
- 6.1 OVERVIEW
- 6.2 SURGICAL ROBOTS
- 6.3 REHABILITATION ROBOTS
- 6.4 NONINVASIVE RADIOSURGERY ROBOTS
- 6.5 HOSPITAL AND PHARMACY ROBOTS
- 6.6 EMERGENCY RESPONSE ROBOTIC SYSTEMS
- 6.7 LOGISTICS/HANDLING ROBOTIC SYSTEMS
- 6.8 IMAGING ROBOTIC SYSTEMS
7 GLOBAL MEDICAL ROBOTICS MARKET, BY APPLICATION
- 7.1 OVERVIEW
- 7.2 NEUROLOGY
- 7.3 ONCOLOGY
- 7.4 ORTHOPEDIC ROBOTIC SYSTEMS
- 7.5 LAPAROSCOPY
- 7.6 CARDIOLOGY
- 7.7 AESTHETIC SURGERY
- 7.8 REHABILITATION
- 7.9 ANGIOGRAPHY
- 7.10 OTHERS
8 GLOBAL MEDICAL ROBOTICS MARKET, BY SETTING
- 8.1 OVERVIEW
- 8.2 HOME-CARE
- 8.3 IN-PATIENT
- 8.4 OUT-PATIENT
9 GLOBAL MEDICAL ROBOTICS MARKET, BY END USER
- 9.1 OVERVIEW
- 9.2 HOSPITALS & CLINICS
- 9.3 SPECIALTY CENTERS
- 9.4 REHABILITATION CENTERS
- 9.5 OTHERS
10 GLOBAL MEDICAL ROBOTICS MARKET, BY REGION
- 10.1 OVERVIEW
- 10.2 NORTH AMERICA
- 10.3 EUROPE
- 10.3.1 GERMANY
- 10.3.2 FRANCE
- 10.3.3 UK
- 10.3.4 ITALY
- 10.3.5 SPAIN
- 10.3.6 PORTUGAL
- 10.3.7 RUSSIA
- 10.3.8 NETHERLANDS
- 10.3.9 CZECH REPUBLIC
- 10.3.10 SWITZERLAND
- 10.3.11 REST OF EUROPE
- 10.4 ASIA-PACIFIC
- 10.4.1 CHINA
- 10.4.2 INDIA
- 10.4.3 JAPAN
- 10.4.4 AUSTRALIA
- 10.4.5 SOUTH KOREA
- 10.4.6 INDONESIA
- 10.4.7 PHILIPPINES
- 10.4.8 MALAYSIA
- 10.4.9 SINGAPORE
- 10.4.10 REST OF ASIA-PACIFIC
- 10.5 REST OF THE WORLD
- 10.5.1 MIDDLE EAST
- 10.5.2 AFRICA
- 10.5.3 LATIN AMERICA
11 COMPETITIVE LANDSCAPE
- 11.1 OVERVIEW
- 11.2 COMPETITIVE BENCHMARKING
- 11.3 MAJOR GROWTH STRATEGY IN THE MEDICAL ROBOTICS MARKET
- 11.4 THE LEADING PLAYER IN TERMS OF NUMBER OF DEVELOPMENTS IN THE MEDICAL ROBOTICS MARKET
- 11.5 KEY DEVELOPMENT ANALYSIS
- 11.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
- 11.6.1 PRODUCT APPROVALS AND PRODUCT LAUNCHES
- 11.6.2 INVESTMENTS/FUNDING
- 11.6.3 BUSINESS EXPANSION
- 11.6.4 MERGERS & ACQUISITIONS
- 11.7 MAJOR PLAYERS SALES ANALYSIS
- 11.7.1 SALES & OPERATING INCOME
- 11.8 MAJOR PLAYERS R&D ANALYSIS
12 COMPANY PROFILE
- 12.1 AURIS HEALTH, INC.
- 12.1.1 COMPANY OVERVIEW
- 12.1.2 FINANCIAL OVERVIEW
- 12.1.3 PRODUCTS/SERVICES OFFERED
- 12.1.4 KEY DEVELOPMENTS
- 12.1.5 KEY STRATEGIES
- 12.2 MEDTRONIC
- 12.2.1 COMPANY OVERVIEW
- 12.2.2 FINANCIAL OVERVIEW
- 12.2.3 PRODUCTS OFFERED
- 12.2.4 KEY DEVELOPMENTS
- 12.2.5 SWOT ANALYSIS
- 12.2.6 KEY STRATEGIES
- 12.3 ZIMMER BIOMET
- 12.3.1 COMPANY OVERVIEWS
- 12.3.2 FINANCIAL OVERVIEW
- 12.3.3 PRODUCTS OFFERED
- 12.3.4 KEY DEVELOPMENTS
- 12.3.5 SWOT ANALYSIS
- 12.3.6 KEY STRATEGIES
- 12.4 RENISHAW PLC.
- 12.4.1 COMPANY OVERVIEW
- 12.4.2 FINANCIAL OVERVIEW
- 12.4.3 PRODUCTS OFFERED
- 12.4.4 KEY DEVELOPMENTS
- 12.4.5 KEY STRATEGIES
- 12.5 HEALTH ROBOTICS S.R.L
- 12.5.1 COMPANY OVERVIEW
- 12.5.2 FINANCIAL OVERVIEW
- 12.5.3 PRODUCTS OFFERED
- 12.5.4 KEY DEVELOPMENTS
- 12.5.5 KEY STRATEGIES
- 12.6 STRYKER
- 12.6.1 COMPANY OVERVIEW
- 12.6.2 FINANCIAL ANALYSIS
- 12.6.3 PRODUCTS OFFERED
- 12.6.4 KEY DEVELOPMENTS
- 12.6.5 SWOT ANALYSIS
- 12.6.6 KEY STRATEGIES
- 12.7 SMITH+NEPHEW
- 12.7.1 COMPANY OVERVIEW
- 12.7.2 FINANCIAL OVERVIEW
- 12.7.3 PRODUCTS OFFERED
- 12.7.4 KEY DEVELOPMENTS
- 12.7.5 SWOT ANALYSIS
- 12.7.6 KEY STRATEGIES
- 12.8 INTUITIVE SURGICAL
- 12.8.1 COMPANY OVERVIEW
- 12.8.2 FINANCIAL OVERVIEW
- 12.8.3 PRODUCTS 0FFERED
- 12.8.4 KEY DEVELOPMENTS
- 12.8.5 SWOT ANALYSIS
- 12.8.6 KEY STRATEGIES
- 12.9 KUKA AG
- 12.9.1 COMPANY OVERVIEW
- 12.9.2 FINANCIAL OVERVIEW
- 12.9.3 PRODUCTS OFFERED
- 12.9.4 KEY DEVELOPMENTS
- 12.9.5 KEY STRATEGIES
- 12.10 CMR SURGICAL
- 12.10.1 COMPANY OVERVIEW
- 12.10.2 FINANCIAL ANALYSIS
- 12.10.3 PRODUCTS OFFERED
- 12.10.4 KEY DEVELOPMENTS
- 12.10.5 KEY STRATEGIES
13 APPENDIX
- 13.1 REFERENCES
- 13.2 RELATED REPORTS